Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bile Duct Obstruction, Intrahepatic

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Bile Duct Obstruction, Intrahepatic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Birke, F; Jamieson, N; Meade, CJ; Metcalfe, S; Neild, G; Watson, C1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bile Duct Obstruction, Intrahepatic

ArticleYear
Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation.
    Journal of lipid mediators and cell signalling, 1994, Volume: 9, Issue:3

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Cholestasis, Intrahepatic; Female; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Liver; Liver Transplantation; Male; Nephrectomy; Phospholipases A; Platelet Activating Factor; Reference Values; Reproducibility of Results

1994